Japan Tobacco Inc. has completed the transfer of its pharmaceutical business to Shionogi & Co., Ltd., finalizing its exit from this segment.

The transaction was executed through a simplified absorption-type split, under which Shionogi assumed full ownership of JT Group’s pharmaceutical operations in line with previously announced agreements. As a result, JT is now fully focused on its core businesses, primarily tobacco and processed food, while Shionogi expands its pharmaceutical portfolio through the integration of the transferred operations.